Showing 1 - 20 results of 23 for search 'S. Dagogo-Jack', query time: 0.07s
Refine Results
-
1
Editorial: Prediabetes and endocrine function by Andile Khathi, Sam Dagogo-Jack
Published 2023-08-01
Article -
2
-
3
-
4
Association of urinary albumin-to-creatinine ratio with cardiometabolic risk markers and pre-diabetes in adults with normoglycemia, normoalbuminuria, and normotension with parental... by Samuel Dagogo-Jack, Jim Wan, Matthew Everett, Natasha Rushing, Peace Asuzu
Published 2024-01-01
Article -
5
-
6
Outcome of lifestyle intervention in relation to duration of pre-diabetes: the Pathobiology and Reversibility of Prediabetes in a Biracial Cohort (PROP-ABC) study by Ibiye Owei, Samuel Dagogo-Jack, Amy A Brewer, Nkiru Umekwe, Renate Rosenthal, Jim Wan, Vamsee Mupparaju
Published 2022-03-01
Article -
7
Extrathoracic Metastases in Pleural Mesothelioma by Ibiayi Dagogo-Jack, MD, Beow Y. Yeap, ScD, Mari Mino-Kenudson, MD, Subba R. Digumarthy, MD
Published 2023-09-01
Article -
8
-
9
Predictive utilities of lipid traits, lipoprotein subfractions and other risk factors for incident diabetes: a machine learning approach in the Diabetes Prevention Program by Samuel Dagogo-Jack, Carlos Lorenzo, Kieren J Mather, Marinella Temprosa, Tibor V Varga, Jinxi Liu, Ronald B Goldberg, Guannan Chen, Xavier Pi-Sunyer
Published 2021-08-01
Article -
10
Exploring racial and ethnic disparities in medication adherence among Medicare comprehensive medication review recipients by Xiaobei Dong, Chi Chun Steve Tsang, Jim Y. Wan, Ya-Chen Tina Shih, Marie A. Chisholm-Burns, Samuel Dagogo-Jack, William C. Cushman, Lisa E. Hines, Junling Wang
Published 2021-09-01
Article -
11
POS-354 WORSENING KIDNEY DISEASE INFLUENCES THE EFFICACY OF ERTUGLIFLOZIN ON GLUCOSURIA-MEDIATED ENDPOINTS BUT DOES NOT INFLUENCE THE EFFICACY ON NATRIURESIS-RELATED ENDPOINTS: PRE... by D. Cherney, B. Charbonnel, F. Cosentino, R.E. Pratley, S. Dagogo-Jack, W.J. Shih, D.K. McGuire, R. Frederich, M. Maldonado, J. Liu, A. Pong, C. Liu, C.P. Cannon
Published 2021-04-01
Article -
12
Racial differences in measures of glycemia in the Vitamin D and Type 2 Diabetes (D2d) Study: a secondary analysis of a randomized trial by Samuel Dagogo-Jack, Erin S LeBlanc, Richard E Pratley, Neda Rasouli, Anastassios G Pittas, Jason Nelson, Ranee Chatterjee, Mary K Rhee, Cyrus V Desouza, Lisa M Neff, Anne M Peters, Daniel S Hsia
Published 2024-01-01
Article -
13
Racial and ethnic disparities in Medicare Part D medication therapy management services utilization by Xiaobei Dong, Chi Chun Steve Tsang, Jamie A. Browning, Joseph Garuccio, Jim Y. Wan, Ya Chen Tina Shih, Marie A. Chisholm-Burns, Samuel Dagogo-Jack, William C. Cushman, Junling Wang, Junling Wang
Published 2023-03-01
Article -
14
TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program. by Jeanne M McCaffery, Kathleen A Jablonski, Paul W Franks, Sam Dagogo-Jack, Rena R Wing, William C Knowler, Linda Delahanty, Dana Dabelea, Richard Hamman, Alan R Shuldiner, Jose C Florez, Diabetes Prevention Program Research Group
Published 2011-01-01
Article -
15
Higher Predictive Value Positive for MMA Than ACA MTM Eligibility Criteria Among Racial and Ethnic Minorities: An Observational Study by Yanru Qiao MS, Christina A. Spivey PhD, Junling Wang PhD, Ya-Chen Tina Shih PhD, Jim Y. Wan PhD, Julie Kuhle BS, Samuel Dagogo-Jack MD, William C. Cushman MD, Marie A. Chisholm-Burns PharmD, MPH, MBA
Published 2018-09-01
Article -
16
A Phase 2 Study of Lorlatinib in Patients With ROS1-Rearranged Lung Cancer With Brain-Only Progression on Crizotinib by Jaime L. Schneider, MD, PhD, Alona Muzikansky, MA, Jessica J. Lin, MD, Elizabeth A. Krueger, NP, Inga T. Lennes, MD, Joseph O. Jacobson, MD, Michael Cheng, MD, Rebecca S. Heist, MD, MPH, Zofia Piotrowska, MD, MHS, Justin F. Gainor, MD, Alice T. Shaw, MD, PhD, Ibiayi Dagogo-Jack, MD
Published 2022-07-01
Article -
17
Efficacy and Tolerability of ALK/MET Combinations in Patients With ALK-Rearranged Lung Cancer With Acquired MET Amplification: A Retrospective Analysis by Ibiayi Dagogo-Jack, MD, Lesli A. Kiedrowski, MS, MPH, Rebecca S. Heist, MD, MPH, Jessica J. Lin, MD, Catherine B. Meador, MD, PhD, Elizabeth A. Krueger, NP, Andrew Do, BS, Jennifer Peterson, BS, Lecia V. Sequist, MD, MPH, Justin F. Gainor, MD, Jochen K. Lennerz, MD, PhD, Subba R. Digumarthy, MD
Published 2023-08-01
Article -
18
Clinicopathologic Characteristics and Outcomes for Patients With KRAS G12D-Mutant NSCLC by Alissa J. Cooper, MD, Alona Muzikansky, MA, Jochen Lennerz, MD, PhD, Farhaana Narinesingh, M.B.B.S., Mari Mino-Kenudson, MD, Yin P. Hung, MD, PhD, Zofia Piotrowska, MD, MHS, Ibiayi Dagogo-Jack, MD, Lecia V. Sequist, MD, MPH, Justin F. Gainor, MD, Jessica J. Lin, MD, Rebecca S. Heist, MD, MPH
Published 2022-09-01
Article -
19
B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung Adenocarcinoma by Ibiayi Dagogo-Jack, MD, Ivan Valiev, MD, Nikita Kotlov, MS, Anna Belozerova, MD, Aleksandra Lopareva, MS, MD, Anna Butusova, MS, Naira Samarina, PhD, Alexandra Boyko, MS, Zhongmin Xiang, PhD, Monique Johnson, BS, Sandrine Degryse, PhD, Florence K. Keane, MD, Lecia V. Sequist, MD, Michael Lanuti, MD, Nathan Fowler, MD, Mari Mino-Kenudson, MD, Alexander Bagaev, PhD
Published 2023-07-01
Article -
20
Phase II study of ipilimumab and nivolumab in leptomeningeal carcinomatosis by Priscilla K. Brastianos, Matthew R. Strickland, Eudocia Quant Lee, Nancy Wang, Justine V. Cohen, Ugonma Chukwueke, Deborah Anne Forst, April Eichler, Beth Overmoyer, Nancy U. Lin, Wendy Y. Chen, Aditya Bardia, Dejan Juric, Ibiayi Dagogo-Jack, Michael D. White, Jorg Dietrich, Naema Nayyar, Albert E. Kim, Christopher Alvarez-Breckenridge, Maura Mahar, Joana L. Mora, Brian V. Nahed, Pamela S. Jones, Helen A. Shih, Elizabeth R. Gerstner, Anita Giobbie-Hurder, Scott L. Carter, Kevin Oh, Daniel P. Cahill, Ryan J. Sullivan
Published 2021-10-01
Article